^
    Back
    Association details:
    Biomarker:No biomarker
    Cancer:Non-Hodgkin’s Lymphoma
    Drug:carboplatin (Tubulin polymerization promoter) +
    cytarabine (DNA synthesis inhibitor, DNA-directed DNAP inhibitor) +
    dexamethasone (GCR agonist)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: A2 - Guideline
    New
    Source:
    NCCN
    Excerpt:
    Extranodal NK/T-Cell Lymphomas…DHA (dexamethasone and cytarabine) + carboplatin (category 2B)